Comparison of immunogenicity elicited by two prime-boost strategies against tuberculosis

被引:0
作者
Lu, M. [1 ]
Bao, L. [1 ]
机构
[1] Sichuan Univ, West China Ctr Med Sci, Chengdu 610064, Peoples R China
关键词
D O I
10.1016/j.ijid.2014.03.1328
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
63.023
引用
收藏
页码:440 / 440
页数:1
相关论文
共 50 条
[11]   Prime-boost strategies for malaria vaccine development [J].
Dunachie, SJ ;
Hill, AVS .
JOURNAL OF EXPERIMENTAL BIOLOGY, 2003, 206 (21) :3771-3779
[12]   Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines [J].
Hu, Zhidong ;
Jiang, Weimin ;
Gu, Ling ;
Qiao, Dan ;
Shu, Tsugumine ;
Lowrie, Douglas B. ;
Lu, Shui-Hua ;
Fan, Xiao-Yong .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2019, 97 (12) :1685-1694
[13]   Improved immunogenicity of mycobacterium tuberculosis Rv0577 by a heterologous prime-boost vaccination strategy in mice [J].
Gu, Dongqing ;
Luo, Tao ;
Chen, Wei ;
Mi, Youjun ;
Gong, Xueli ;
Bao, Lang .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (03) :2774-2783
[14]   Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines [J].
Zhidong Hu ;
Weimin Jiang ;
Ling Gu ;
Dan Qiao ;
Tsugumine Shu ;
Douglas B. Lowrie ;
Shui-Hua Lu ;
Xiao-Yong Fan .
Journal of Molecular Medicine, 2019, 97 :1685-1694
[15]   Prime-boost strategies to embrace diversity and inclusion in immunology [J].
Butts, Cherie L. ;
Ricks, Irelene P. ;
August, Avery .
NATURE REVIEWS IMMUNOLOGY, 2016, 16 (12) :715-716
[16]   Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis [J].
Brennan, Michael J. ;
Clagett, Bartholt ;
Fitzgerald, Hillary ;
Chen, Vicki ;
Williams, Ann ;
Izzo, Angelo A. ;
Barker, Lewellys F. .
VACCINE, 2012, 30 (18) :2811-2823
[17]   Factors influencing the protective efficacy of a BCG homologous prime-boost vaccination regime against tuberculosis [J].
Griffin, JFT ;
Mackintosh, CG ;
Rodgers, CR .
VACCINE, 2006, 24 (06) :835-845
[18]   Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens [J].
Tan, Wendy G. ;
Zubkova, Iryna ;
Kachko, Alla ;
Wells, Frances ;
Adler, Heiko ;
Sutter, Gerd ;
Major, Marian E. .
PLOS ONE, 2017, 12 (07)
[19]   Immunogenicity and protective efficacy of prime-boost regimens with recombinant multivalent BCG and modified vaccinia virus Ankara expressing tuberculosis antigens providing protection against Mycobacterium tuberculosis [J].
Lee, C. -F. ;
Chou, R. -W. ;
Chi, H. -H. ;
Yeh, C. -T. ;
Chang, W. .
FEBS JOURNAL, 2013, 280 :274-274
[20]   Immunogenicity and protective efficacy of heterologous prime-boost regimens with mycobacterial vaccines and recombinant adenovirus- and poxvirus-vectored vaccines against murine tuberculosis [J].
You, Qingrui ;
Wu, Yongge ;
Wu, Yang ;
Wei, Wei ;
Wang, Changyong ;
Jiang, Dehua ;
Yu, Xianghui ;
Zhang, Xizhen ;
Wang, Yong ;
Tang, Zhijiao ;
Jiang, Chunlai ;
Kong, Wei .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (11) :E816-E825